Portfolio License
Your portfolio companies negotiate deals you hear about at the board meeting. Change that.
Solidus gives your entire portfolio access to institutional-grade deal benchmarking — so every licensing conversation starts with verified comparable data, not guesswork. You see every deal across the portfolio before it signs.
What the Portfolio License includes
Full 21-engine access for every seat
Deal terms, rNPV, Monte Carlo, partner matching, buyer-specific valuation, competitive dynamics, real options, milestone optimization — all 21 engines, unlimited calculations.
Admin dashboard
Real-time visibility into which portfolio companies are benchmarking, what comps they're pulling, and where deal conversations are heading. No more status update emails.
Cross-portfolio pipeline tracker
See active deal conversations across all portfolio companies. Catch conflicts — two companies approaching the same partner uncoordinated — before they become problems.
Dedicated analyst hours
Every contract includes analyst hours from the Ambrosia team. Task them with custom comp sets, bespoke deal memos, or ad-hoc research. Delivered fund-branded.
Fund-branded reports
Every output comes with your fund's logo and disclaimers. Portfolio CEOs share with their boards — your branding is on the analysis, not ours.
Quarterly portfolio benchmarking report
A bespoke quarterly report covering deal landscape, company-specific benchmarks, and an LP-ready exec summary. Assembled by Ambrosia analysts.
Pricing
The ROI math
Average Phase 2 licensing deal: $200-500M total value. Improvement needed to break even on a $60K Scale subscription: 0.012%. One better-negotiated milestone structure in one deal pays for a decade of Solidus.
For context: a single outside counsel engagement on a complex licensing deal costs $75-100K. The Scale tier is $60K/yr for 10 seats — every deal, every company, all year.